Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.490
-0.030 (-0.85%)
Apr 27, 2026, 4:00 PM EDT - Market closed
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $380.84 million as of April 27, 2026. Its market cap has decreased by -27.71% in one year.
Market Cap
380.84M
Enterprise Value
216.79M
1-Year Change
-27.71%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $380.84M, an increase of 299.62%. That is a compound annual growth rate of 13.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 378.90M | -0.26% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 386.09M |
| Avalo Therapeutics | 385.22M |
| Enanta Pharmaceuticals | 384.65M |
| YD Bio | 383.95M |
| X4 Pharmaceuticals | 382.77M |
| Puma Biotechnology | 382.08M |
| Autolus Therapeutics | 377.92M |
| Immuneering | 372.66M |